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Since the mid-19th century, trichinellosis has been a well-recognized meat-borne zoonosis; however, despite concerted control efforts, it remains a threat in many countries. Veterinary control over the slaughter of food animals to ensure food safety, particularly meat inspection, was introduced in Germany in 1866 specifically to prevent trichinellosis from pork infected with the muscle larvae of *Trichinella spiralis* ([@R-2-1]). In the European Union, the estimated annual cost incurred from meat inspection of 167 million pigs ([@R-2-2]) ranges from €25 million to €400 million ([@R-2-3]). Even in countries without mandatory meat inspection (e.g., United States), the economic cost of selling pork in international and national markets is substantial ([@R-2-4]).

The epidemiology and systematics (i.e., the study of the diversification) of this zoonosis are now recognized to involve, in addition to *T. spiralis*, 7 other species in 4 genotypes, all of which are more commonly found in wild animals than in domestic pigs ([@R-2-5]). *Trichinella* spp. have been found in domestic and wild animals in 66 countries ([@R-2-6]). Human trichinellosis has been documented in 55 countries, particularly those with well-established food behavior that includes consuming meat dishes with raw or undercooked meat ([@R-2-6]). Whether trichinellosis is a low-prevalence disease or is frequently misdiagnosed is not clearly understood; its detection can be difficult in low-level infections and its clinical manifestations overlap those of other diseases, such as influenza and chronic fatigue syndrome ([@R-2-7]). Human infection is classically characterized by gastroenteritis; myalgia; malaise; facial edema; headache; subungual or conjunctival hemorrhages; and increased eosinophils, leukocytes, and muscle enzymes ([@R-2-7]).

Reliable estimates of the incidence of trichinellosis among humans and its effect on health are not available; these estimates are necessary for setting priorities. In the 1990s, the global prevalence of trichinellosis was ≈10 million, and a recent incidence estimate suggested ≈10,000 infections per year ([@R-2-6]). However, because of problems related to incomplete data from some regions and to the quality of diagnostic criteria for infection, the Foodborne Disease Burden Epidemiology Reference Group of the World Health Organization (WHO) requested a systematic review of the global incidence, burden of disease, and major sources of infection that used strict criteria for data selection and extraction. Our analyses and summaries of the epidemiologic and clinical data selected provide a basis for an assessment of trichinellosis as a public health problem.

Data Sources and Selection Criteria
===================================

We retrospectively reviewed trichinellosis outbreak investigations conducted worldwide during 1986--2009. The data analysis focused on incidence, age and sex of patients, infection rates, major clinical aspects (including sequelae), and meat sources of infection. The database we developed was geographically organized according to the WHO regions ([www.who.int/choice/demography/regions/en](http://www.who.int/choice/demography/regions/en)): African Region, 46 countries; Region of the Americas, 12 countries; Eastern Mediterranean Region, 22 north African and Middle Eastern countries; European Region, 44 European and 6 Asian countries; South-East Asian Region, 11 east Asian countries; and Western Pacific Region, 27 countries. Data searches of literature included PubMed, Centres for Agricultural Bioscience International (CABI) abstracts, WHO library, System for Information on Gray Literature, Pan America Health Organization Virtual Library, and Index Medicus for South-East Asian Region.

The search terms used were trichinosis, trichinellosis, trichinelliasis, and trichinella. These were combined with the terms prevalence, outbreaks, epidemiology, clinical symptoms, and duration. The search terms were also combined with pork, pig, wild boar, wild pig, warthog, horse, badger, jackal, cougar, walrus, armadillo, turtle, and bear meat. Published abstracts were screened for retention by using the criteria of relevance to human outbreaks or single cases occurring from 1986 through 2009 and by determining whether the report was based on original data (primary source or unpublished data managed by national government agencies). The full paper versions of selected abstracts were then obtained where possible and further screened and evaluated. Outbreak reports published \>1 time were occasionally encountered, and care was taken to prevent duplication of data in the database; preference was given to published international, peer-reviewed versions. In some instances, data were obtained through contact with scientists in countries of interest who had access to unpublished and detailed information about outbreaks; these sources are indicated in the reference lists in the [Technical Appendix](#SD1){ref-type="local-data"}. In addition, information about isolated outbreaks maintained by a national health system was obtained for some countries through personal contacts (see Acknowledgments). For reports in which English versions were not available, translations were obtained through the generous help of colleagues (see Acknowledgments).

Definitions
===========

Reports, published or unpublished, were excluded from the database if the diagnosis of *Trichinella* spp. infection was not based on a diagnostic procedure that we defined as confirmatory. Although direct demonstration of muscle larvae infection in biopsy samples is now infrequent, reliance solely on serologic testing to confirm infection can be problematic ([@R-2-8]). Therefore, a serologically positive case was included in the database only if the sample was confirmed by a Western blot test or if the patient's illness could be classified as highly probable according to the clinical diagnostic algorithm published by Dupouy-Camet and Bruschi ([@R-2-7]), in which a patient with a positive serologic test result must also exhibit [\>]{.ul}1 classical trichinellosis signs and symptoms (e.g., myalgia, facial edema, headaches, diarrhea, eosinophilia).

We took a conservative approach in extracting clinical data for the analysis of frequency of major signs and symptoms in patients with *Trichinella* spp. infections and excluded report data if there was lack of clarity and reliability of clinical procedures and laboratory tests used to confirm infection. However, in some instances of inadequate clinical descriptions, the report was retained if it otherwise presented useful epidemiologic data. Consequently, the total number of human infections ([Table 1](#T-2-1){ref-type="table"}, [Table 2](#T-2-2){ref-type="table"}, [Table 3](#T-2-3){ref-type="table"}) exceeds the number of cases used to summarize the frequency of major signs and symptoms ([Table 4](#T-2-4){ref-type="table"}). Except in rare cases, clinical data were extracted from outbreak reports only if the data were from multiple cases that met these criteria; exceptions were reports of single cases from countries with rare occurrences of trichinellosis but that had good clinical and laboratory confirmation data (e.g., Korea, Japan, India).

###### Clinically confirmed cases of trichinellosis in humans documented in World Health Organization regions, 1986--2009

  Region (no. countries)              No. (%) countries with trichinellosis   No. (%) documented human infections   No. (%) deaths
  ----------------------------------- --------------------------------------- ------------------------------------- ----------------
  African Region (46)                 1 (2.17)                                28 (0.04)                             1 (3.57)
  Region of the Americas (12)         5 (42.67)                               7,179 (10.90)                         10 (0.10)
  Eastern Mediterranean Region (22)   2 (9.09)                                50 (0.07)                             0
  European Region (50)                29 (58.00)                              56,912 (86.47)                        24 (0.04)
  South-East Asian Region (11)        1 (9.69)                                219 (0.33)                            1 (0.50)
  Western Pacific Region (27)         3 (11.11)                               1,344 (2.04)                          6 (0.40)
  Other\*                             NA                                      86 (0.13)                             0
  Total (168)                         41 (24)                                 65,818 (100.00)                       42 (0.40)

\*Infections acquired in countries other than the one in which diagnosis occurred. NA, not applicable

###### Total cases and incidence of *Trichinella* spp. infections, by World Health Organization region and country, 1986--2009\*

  Region/country                 Years        No. cases   Average incidence†
  ------------------------------ ------------ ----------- --------------------
  African Region, Ethiopia       1986         8           0.02
                                 1990         20          0.04
  Region of the Americas                      7,179       
  Argentina                      1990--2005   5,221       1.48
  Canada                         1987--2009   257         0.03
  Chile                          1991--2004   698         0.36
  Mexico                         1986--2001   351         0.02
  United States                  1987--2007   652         0.016--0.004
  Eastern Mediterranean Region                50          
  Iran                           2007         6           0.008
  Lebanon                        1995         44          1.25
  European Region                             56,912      
  Belarus                        1988, 1989   16          0.08, 0.55
  Bosnia and Herzegovina         1993--2003   1,600       0.1--8.0
  Bulgaria                       1990--2006   4,108       2.9
  Croatia                        1994--2009   2,110       0.02--12.3
  Czech Republic                 1986--2009   31          0.01
  Estonia                        1986--2009   91          0.0--2.9
  France                         1986--2009   1,203       0.00--0.95
  Georgia                        1988         3           0.05
  Germany                        1986--2009   185         0.00--0.01
  Greece                         2009         1           0.008
  Hungary                        1986--2009   158         0.18--0.057
  Ireland                        2007         2           0.04
  Israel                         2002, 2004   230         0.5, 3.0
  Italy                          1986--2009   1,181       0.0--0.9
  Kyrgyzstan                     1996         10          0.2
  Latvia                         1986--2009   636         0.07--3.8
  Lithuania                      1989--2009   3,979       0.4--21.8
  Macedonia                      1992         6           0.3
  Poland                         1986--2007   3,084       0.05--1.5
  Romania                        1986--2007   28,564      1.7--16.1
  Russia                         1996--2002   971         0.3--0.6
  Serbia                         1994--2003   5,210       1.8--7.8
  Slovakia                       1986--2008   440         0.0--6.2
  Slovenia                       1989--2006   203         0.00--10.5
  Spain                          1986--2009   1,244       0.0--0.4
  Switzerland                    1994, 2009   4           0.01, 0.04
  Turkey                         2003, 2004   425         0.01, 0.59
  United Kingdom                 1999         7           0.01
  Ukraine                        1986--2009   1,210       0.00--0.30
  South-East Asian Region                     219         
  India                          1996--2002   3           0.0003
  Thailand                       1993--2007   216         0.35
  Western Pacific Region                      1,344       
  Japan                          1999--2005   4           NA
  South Korea                    1999--2003   8           0.016
  Laos                           2004--2006   123         2.09
  People's Republic of China     1995--2009   1,137       NA
  Singapore                      1998         25          0.64
  Vietnam                        2001--2004   47          0.058

\*The detailed data and references for each country are available in the [Technical Appendix](#SD1){ref-type="local-data"}, section A. NA, insufficient data for incidence calculation. †Incidence/100,000 person-years. For some countries, incidence was not reported and was calculated from data available in the report referenced.

###### Trichinellosis acquired in locations different from those where the disease developed and was diagnosed, 1986--2009\*

  Country where infection developed and was diagnosed   Country where infection was acquired (no. clinical cases)
  ----------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------
  Austria                                               Yugoslavia (10)
  Belgium                                               Canada (1)
  Czech Republic                                        Poland (2), Ukraine (2), France (1)
  Denmark                                               Poland (12)
  France                                                Algeria (6), Cameroon (1), Canada (13), Croatia (1), Greenland (2), Kenya (2), Laos (5), Senegal (5), Spain (1), Thailand (1), Turkey (3), Yugoslavia (1)
  Germany                                               Canada (1), Poland (3)
  Italy                                                 Romania (4)
  The Netherlands                                       Yugoslavia (3), Montenegro (5)
  Hong Kong                                             Canada (1)

\*Complete data and references are available in the [Technical Appendix](#SD1){ref-type="local-data"}, section B.

###### Frequency of major clinical signs associated with trichinellosis among World Health Organization regions, 1986--2009\*

  Region                         Total no. cases†   Clinical sign, no. cases   Deaths                                                                   
  ------------------------------ ------------------ -------------------------- -------------- -------------- -------------- ------------ -------------- ----------
  African Region                 28                 28                         8              11             8              6            6              0
  Region of the Americas         1,229              400                        969            821            790            410          606            10
  Eastern Mediterranean Region   45                 43                         42             41             Not reported   30           0              4
  European Region                3,118              798                        1,971          1,387          1,617          351          1,850          24
  South-East Asian Region        210                82                         206            103            102            71           97             1
  Western Pacific Region         747                79                         409            474            429            104          180            8
  Total no. (%)                  5,377 (100.0)      1,430 (27.0)               3,605 (67.0)   2,837 (53.0)   2,946 (55.0)   972 (18.0)   2,739 (51.0)   35 (1.0)

\*Report references are available in the [Technical Appendix](#SD1){ref-type="local-data"}, section C. †Cases included in this table were selected from all reports on the basis of detailed descriptions of clinical data in the reports.

From the original 494 abstracts identified from literature searches, 378 were judged to potentially meet the criteria for data extraction, and full articles were obtained for most abstracts. From these, 261 reports were retained for data extraction and inclusion. A major reason for rejection of articles was failure to meet the criteria for confirmation of infection, especially interpretation of serologic results.

Incidence
=========

In [Table 2](#T-2-2){ref-type="table"}, the incidence (100,000 person-years) is reported for specific periods because the data were obtained over a shorter period than the formal study interval (1986--2009). For some countries, when incidence figures were not reported in published papers or national health reports, we calculated incidence from data available in the referenced reports by using the WHO World Population Prospects (the 2008 revision) (<http://esa.un.org/wpp/unpp/p2k0data.asp>). Overall, from 1986 through 2009, there were 65,818 cases and 42 deaths from trichinellosis reported from 41 countries ([Tables 1](#T-2-1){ref-type="table"}--[3](#T-2-3){ref-type="table"}). The European Region accounted for 86% of cases (56,912), of which 28,564 (50%) occurred in Romania, mainly during 1990--1999. The full references for specific country reports summarized in [Tables 2](#T-2-2){ref-type="table"}--[5](#T-2-5){ref-type="table"} are available in the [Technical Appendix](#SD1){ref-type="local-data"}.

###### Demographic data on trichinellosis patients, by World Health Organization region and country, 1986--2009

  Region/country                          \% Male patients (total no. cases)†   Age, y, of infected persons (no. cases)
  --------------------------------------- ------------------------------------- -------------------------------------------------------
  African Region: Ethiopia                100 (28)                              Range 23--25 (3); mean 24 (3)
  Region of the Americas                                                        
  Canada                                  62.1 (150)                            Range 21--67 (85); mean 34.4 (65)
  Chile                                   60 (667)                              Range 5--70 (667)
  Mexico                                  35 (59)                               Range 25--44 (59)
  United States                           57.5 (632)                            Range 1--87 (412); mean 42.0 (126); median 37.1 (232)
  Eastern Mediterranean Region: Lebanon   54 (44)                               Range 10--70 (44); mean 33 (44)
  European Region                                                               
  Bulgaria                                49 (228)                              Range 1--70 (228)
  Croatia                                 57 (200)                              Range 3--67 (200); mean 35 (200)
  Czech Republic                          41.9 (31)                             Range 9--68 (31); mean 35.9 (31)
  France                                  51.4 (586)                            Range 1--84 (581); mean 43.8 (581)
  Germany                                 51.9 (104)                            Range 1--73 (101); mean 34.8 (101)
  Israel                                  100 (26)                              Mean 32 (26)
  Italy                                   50.3 (382)                            Range 1--90 (368); mean 36.7 (368)
  Romania                                 53.2 (521)                            Range 1- \>60 (521); mean 31.4 (521)
  Slovakia                                63.6 (11)                             Range 16--80 (21); mean 40.5 (21)
  Spain                                   57.5 (237)                            Range 2--86 (140); mean 40.7 (177)
  Turkey                                  52.6 (418)                            Range 1.5--73 (418); mean 31.1 (418)
  South-East Asian Region: Thailand       71 (165)                              Range 7--70 (210); mean 35.6 (208); median 34.5 (140)
  Western Pacific Region                                                        
  Laos                                    47 (111)                              Range 5--69 (111); mean 30.4 (90); median 34 (21)
  People's Republic of China              58.2 (802)                            Range 1--90 (482)
  Vietnam                                 92 (42)                               Range 20--60 (42); mean 45.4 (42)
  Singapore                               56 (25)                               Mean 22.5 (25)

\*Clinical details and report references are available in the [Technical Appendix](#SD1){ref-type="local-data"}, section D. †Data are from reports that presented adequate sex and age data on [\>]{.ul}10 cases during 1986--2009.

Of 46 countries in the African Region, trichinellosis has been documented only among soldiers in the Gojjam region and policemen in the Arsi region of Ethiopia, a country where the Christian population accounts for ≈60% of the total population. In the Eastern Mediterranean Region, trichinellosis was documented only in the Christian population of Lebanon and in Iran from the consumption of wild boar meat ([Table 2](#T-2-2){ref-type="table"}). In Algeria and Senegal, where most of the population is Muslim, trichinellosis has been documented only in Europeans ([@R-2-6]).

In the European Region, 4 epidemiologic patterns are discernable: 1) countries of eastern Europe where incidence rates are \>1 case/100,000 inhabitants (Bosnia-Herzegovina, 4.1; Bulgaria, 2.4--2.9; Croatia, 1.7--4.8; Latvia, 1.1--1.3; Lithuania, 1.2--6.6; Romania, 2.9--8.5; and Serbia, 5.0); 2) countries with a low number of inhabitants where the occurrence of a large outbreak results in a high incidence rate (e.g., Israel, 3.0; Slovakia, 6.2; and Slovenia, 10.5); 3) 19 countries with a low incidence rate caused either by sporadic infections or by a large general population that reduces the incidence per 100,000 inhabitants even when a large outbreak occurs; and 4) 21 countries where no autochthonous infections were reported during the period. Incidence in eastern Europe spiked during the late 1980s and early 1990s and then decreased over the past decade. This pattern may be linked to the political, social, and economic changes that occurred with the breakup of the former Soviet Union as described by Djordjevic et al. ([@R-2-9]). The gradual restoration of infrastructure related to food safety (e.g., meat inspection, pig production management, veterinary services) probably contributed substantially to the decrease in incidence in these countries.

The number of cases in the Region of the Americas was comparatively low ([Table 1](#T-2-1){ref-type="table"}), except in Argentina ([Table 2](#T-2-2){ref-type="table"}). National incidence estimates are limited for Region of the Americas countries and published only for the United States, Chile, and Argentina; data from Canada, Mexico, and Argentina pertain only to selected states, provinces, or districts that had large outbreaks. In Canada during the period, a few large outbreaks in northern communities among native people who consumed wild game accounted for most of the outbreaks in the country. As an example of the problem of informal or clandestine meat transportation, 2 outbreaks occurred among foreign hunters; in 1 outbreak, the hunters transported infected bear home (France) and unknowingly exposed friends and family (17 total cases). For Canada and Greenland, trichinellosis was caused by consumption of wild game harboring *T. nativa*, which does not infect swine; no pork-transmitted *Trichinella* spp. have been recorded in Canada for many years.

The risk for trichinellosis has decreased markedly in the United States and Chile since the 1990s. The large number of cases associated with Argentina contrasts with the situation among other countries in South America. The cases in Argentina may be related to the European origins of persons immigrating there and the risky food behavior they brought with them ([@R-2-10]). Although incidence data from Mexico and Argentina are limited, trichinellosis outbreaks are reported frequently in Argentina from domestic pork, indicating that a substantial pig husbandry risk persists in that country.

The Asian countries of the Western Pacific Region and the South-East Asian Region reported few outbreaks during the period ([Tables 1](#T-2-1){ref-type="table"}, [2](#T-2-2){ref-type="table"}). Although large outbreaks in the People's Republic of China have been reported ([@R-2-11]), the criteria for selection of reports and data extraction eliminated some reports because of insufficient diagnostic detail to meet the confirmation criteria. Most of the outbreaks reported from Thailand, Laos, and Vietnam, occurred in the northern mountainous regions among the indigenous people who practice free-roaming pig husbandry ([@R-2-12]*--*[@R-2-14]). After a 30-year period of no reports of trichinellosis cases, Laos recently experienced several outbreaks ([@R-2-12]). The estimated incidence in rural areas of that country is high, which suggests a possible emerging problem there.

Globally, reporting of trichinellosis varies greatly. A major factor affecting the collection of epidemiologic and clinical data is an absent or inadequate national reporting system. For example, in some countries of eastern Europe (e.g., Bosnia-Herzegovina, Byelorussia, Georgia, Moldavia, Romania, Russia, Ukraine) trichinellosis occurs frequently in villages during the winter, and infection might not be diagnosed and subsequently reported unless infection is sufficiently severe to require hospitalization or the cases are part of a larger outbreak that requires attention from public health authorities (A. Marinculic, M.C. Cretu, W. Kociecka, N. Iashvili, N. Bogatko, pers. comm.). For example, in Romania, most of the 20,059 cases documented during 1990--1999 pertain to hospitalized persons only. However, for each hospitalized person, there are probably others in whom a moderate or mild infection developed that did not justify the travel and costs that would be incurred in seeking attention for diagnosis and treatment. Consequently, they are not usually officially recorded as having trichinellosis (M.C. Cretu, pers. comm.). In countries where most of the population is Muslim, *Trichinella* spp. infection is rare and may not be reported at all because of a scarcity of physicians, lack of good diagnostic tools, and occurrence in remote areas. In contrast, in industrialized countries such as those of Western Europe, United States, and Canada, nearly all cases are more likely to be detected and recorded, including asymptomatic cases associated with large outbreaks. For these reasons, the data we present may underrepresent the incidence of trichinellosis in lesser developed countries in comparison to that in industrialized and affluent countries.

Sex- and Age-specific Infection
===============================

Data from clinical reports ([Table 5](#T-2-5){ref-type="table"}) demonstrate that trichinellosis is a disease primarily of adults, occurring about equally among both sexes (2,631 \[51%\] of 5,154 infections occurred in male patients). Infection in male patients did occur more frequently, however, in Ethiopia (100%), Vietnam (91%), Japan and South Korea (75%), Thailand (64%), and China (57%). Age-specific infection data ([Table 5](#T-2-5){ref-type="table"}) show the highest proportion of cases, for both sexes, was among persons 20--50 years of age (median 33.1 years). Data on age-specific prevalence rates were rarely reported; however, recent improvements in diagnosis of trichinellosis, particularly immunodiagnostic methods, may encourage more human prevalence surveys and surveillance for trichinellosis that could yield better information about sex- and age-specific rates.

Although infections also occur in children and teenagers, the predominance of infection in adults probably results from culture-driven food behavior. Improperly cooked or prepared meat dishes may be more commonly eaten at adult-oriented events, particularly if alcohol is consumed. There are only a few published studies on the link between food behavior and trichinellosis ([@R-2-15]*,*[@R-2-16]), but this potential behavioral risk factor is similar to that that occurs in other foodborne parasites, such as fish-borne parasites ([@R-2-17]).

Clinical Signs and Sequelae
===========================

For 5,377 cases, the chief clinical signs of trichinellosis were compatible in type and frequency with the classical trichinellosis syndrome ([@R-2-7]), i.e., myalgia, diarrhea, fever, facial edema, and headaches that, after treatment, disappeared within 2--8 weeks ([Table 4](#T-2-4){ref-type="table"}). Their rapid recovery reflects improvements in diagnostic methods, drug therapy, and public health education. The more rapid diagnosis and treatment in recent decades may also account for the low death rate; 42 deaths occurred worldwide during the 24-year period. Determining the disease burden of trichinellosis, however, is hampered by lack of data on the long-term sequelae of infection; few clinical reports included posttreatment follow-up evaluations, particularly beyond 1 month. The few studies that included follow-up over a longer time span indicate that myalgia and fatigue can persist for 4 months and, in a substantial proportion of cases, for up to 2 years ([@R-2-18]*--*[@R-2-20]). There is a need for internationally recognized epidemiologic and clinical protocols for trichinellosis outbreaks that include follow-up investigations that would facilitate reliable calculations of disease estimates.

Sources of Infection
====================

Domestic pigs and wild boars were the major sources of *Trichinella* spp. infection for humans, but in recent years new infection sources, particularly from exotic hosts, have emerged ([Table 6](#T-2-6){ref-type="table"}). An example is the cause of outbreaks in France, where in addition to wild boar sources, most trichinellosis cases for the past 2 decades have resulted from consumption of raw horse meat, a strong food preference in French culture ([@R-2-21]). In Italy, human infections from consumption of horse meat have also been documented in 2 areas (Emilia Romagna and Lombardy regions in northern Italy and the Apulia region in southern Italy), where the French fondness for raw horse meat was introduced centuries ago ([@R-2-16]). In China and the Slovak Republic, dog meat was the source of infection in several outbreaks ([@R-2-22]*,*[@R-2-23]). Although Judaic and Muslim religions forbid the consumption of pork, in Israel, Lebanon, and Syria human outbreaks of trichinellosis have occurred after consumption of meat from wild boars among the Christian Arab population and immigrant laborers ([@R-2-24]*--*[@R-2-27]). Muslim populations are not entirely protected from acquiring trichinellosis, however, as demonstrated by a large outbreak in Turkey from the consumption of minced beef illegally mixed with pork of unknown origin ([Table 2](#T-2-2){ref-type="table"}) ([@R-2-28]).

###### Types of meat linked to trichinellosis cases and outbreaks in the world, by World Health Organization region and country, 1986--2009\*

  Region/country                                                 Meat source, % cases or outbreaks         
  -------------------------------------------------------------- ----------------------------------- ----- --------------------
  African Region: Ethiopia                                       0                                   100   0
  Region of the Americas                                                                                   
  Argentina, Chile                                               100                                 0     0
  Canada                                                         0                                   100   0
  United States                                                  57                                  43    0
  Mexico                                                         86                                  0     14 (horse)
  Eastern Mediterranean Region: Iran and Lebanon                 0                                   100   0
  European Region                                                                                          
  Belarus, Croatia, Georgia, Macedonia, Serbia, United Kingdom   100                                 0     0
  Estonia, Turkey, Ukraine                                       50                                  50    0
  France                                                         0                                   65    35 (horse)
  Germany                                                        83                                  17    0
  Greece, Israel                                                 0                                   100   0
  Hungary                                                        52                                  48    0
  Italy                                                          38                                  38    24 (horse)
  Lithuania                                                      48                                  52    0
  Poland                                                         41                                  59    0
  Romania                                                        95                                  5     0
  Slovakia                                                       50                                  25    25 (dog)
  Spain                                                          60                                  40    0
  South-East Asian Region: Thailand                              50                                  50    0
  Western Pacific Region                                                                                   
  People's Republic of China                                     86                                  13    1 (dog and others)
  Japan                                                          25                                  75    0
  South Korea                                                    0                                   100   0
  India, Laos, Papua New Guinea                                  50                                  50    0
  Singapore, Vietnam                                             100                                 0     0

\*Data for each country aggregated from our database of studies. Data are from reports cited in the [Technical Appendix](#SD1){ref-type="local-data"}, section A.

The demographic movements of humans with culturally unique food practices, the illegal importation of uncontrolled meat from trichinellosis-endemic to -nonendemic countries, and the introduction of risky new food practices have resulted in cases in Denmark, Germany, Italy, Spain, Sweden, and the United Kingdom ([Tables 2](#T-2-2){ref-type="table"}, [3](#T-2-3){ref-type="table"}) ([@R-2-29]*--*[@R-2-33]). Many cases of trichinellosis have occurred among international travelers who acquired *Trichinella* spp. infections while visiting or hunting in disease-endemic areas and the disease developed after they returned to their home countries ([Table 3](#T-2-3){ref-type="table"}) ([@R-2-34]*--*[@R-2-38]).

Issues Affecting the Effective Control of Trichinellosis
========================================================

Human behavior is the biggest determinant in the persistence of trichinellosis in the face of increasing regulations directed at ensuring the safety of meat and the enhancement of good management practices in farming, especially in areas in which trichinellosis is highly endemic, such as the European and the Americas regions. Of particular concern is an increase in the association of wild animals with domestic pigs. For example, in the United States, the expansion of the range of feral pigs (wild boars) into major areas of pig production, including free-range systems, may increase the risk for incursion of *Trichinella* spp. into the human food chain ([@R-2-39]). The increased frequency of outbreaks from eating pork from wild boars in Europe is believed to be related to the great increase in wild boar populations ([@R-2-40]). As with other foodborne zoonoses, cultural traditions in food behavior and practices in the use of domestic and wild animals are not easily altered, and trichinellosis can be expected to remain a food-safety risk in many areas of the world for the foreseeable future.
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**1. You are seeing a 40-year-old man with a 1-month history of myalgia, diarrhea, and intermittent fever. He has a history of eating raw meat on a hunting trip 6 weeks ago.You suspect that this patient might have trichinellosis. What should you consider regarding the epidemiology of trichinellosis in the current study?**A. Trichinellosis was particularly common among MuslimsB. Western Europe had higher rates of trichinellosis compared with Eastern EuropeC. The prevalence of trichinellosis in the United States has risen dramaticallyD. Argentina has the highest prevalence of trichinellosis in South America**2. Which of the following epidemiologic trends in trichinellosis was most pronounced in the current study?**A. Children had higher rates of trichinellosis compared with adultsB. Adults had higher rates of trichinellosis compared with childrenC. Women had higher rates of trichinellosis compared with menD. Men had higher rates of trichinellosis compared with women**3. What should you consider regarding the diagnosis and treatment of trichinellosis in this patient?**A. Symptoms of myalgia, diarrhea, and fever are commonB. Symptoms usually resolve within a few days of the initiation of therapyC. No long-term sequelae to infection have been describedD. Trichinellosis is still usually fatal**4. Which of the following animals was the most common source of trichinellosis in the current study?**A. HorseB. DogC. CowD. Pig
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###### Technical Appendix

Additiona information on Trichinellosis infections and resources used in this study.
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